Related Experiment Videos
Treatment of short stature and delayed adolescence
Insights
Growth hormone (GH) therapy is only noncontroversial for children with documented GH deficiency. While potentially useful for Turner syndrome and NVSS, further research is needed to confirm long-term safety and efficacy.
Area of Science:
- Pediatric Endocrinology
- Growth Disorders
- Hormone Therapy
Background:
- Growth hormone (GH) deficiency is a primary indication for GH therapy in children.
- Emerging evidence suggests potential benefits of GH in specific conditions like Turner syndrome and NVSS.
- The use of GH in non-deficient children is controversial and generally not recommended.
Purpose of the Study:
- To review the established and potential indications for growth hormone therapy in children.
- To highlight the need for further research on the efficacy and safety of GH in specific pediatric populations.
- To emphasize the inappropriate use of GH in non-GH deficient children.
Main Methods:
- Literature review of studies on growth hormone therapy in pediatric populations.
- Analysis of current guidelines and expert opinions on GH indications.
- Evaluation of data regarding efficacy and safety in different conditions.
Main Results:
- Growth hormone therapy is unequivocally indicated for documented GH deficiency in children.
- GH therapy shows promise for children with Turner syndrome and NVSS, but requires further investigation.
- GH treatment for non-GH deficient children within normal growth parameters is inappropriate.
Conclusions:
- The primary, non-controversial use of GH therapy is for documented GH deficiency.
- Long-term efficacy and safety data are crucial for expanding GH indications to conditions like Turner syndrome and NVSS.
- Physicians should avoid prescribing GH for children without confirmed deficiency, irrespective of parental requests.
Abstract:
The treatment of growth failure in children with documented GH deficiency remains the only noncontroversial indication for GH therapy. There are increasing data suggesting that GH may be useful in treating some children with Turner's syndrome and with NVSS. Further studies, however, are necessary to evaluate the long-term efficacy and safety of GH therapy in these children. The treatment of non-GH deficient children whose heights are within two standard deviations of the mean height for age is clearly inappropriate and should be avoided, despite parental protests.